Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

After-Hours Movers: Weber Gains on Takeover Offer, Discover Financial Falls on EPS

Published 10/24/2022, 05:54 PM
Updated 10/24/2022, 05:57 PM
© Reuters.  After-Hours Movers: Weber Gains on Takeover Offer, Discover Financial Falls on EPS

After-Hours Stock Movers:

Weber Inc (NYSE:WEBR24% HIGHER; large shareholder BDT Capital offered to acquire the shares it does not currently own for $6.25 per share.

Medpace Holdings (NASDAQ:MEDP) 20% HIGHER; reported Q3 EPS of $2.05, $0.58 better than the analyst estimate of $1.47. Revenue for the quarter came in at $383.7 million versus the consensus estimate of $357.17 million. Medpace Holdings sees FY2022 EPS of $6.88-$7.00, versus the consensus of $6.15. Medpace Holdings sees FY2022 revenue of $1.44-1.46 billion, versus the consensus of $1.41 billion.

Aaron's (NYSE:AAN) 16% HIGHER; reported Q3 EPS of $0.31, $0.19 better than the analyst estimate of $0.12. Revenue for the quarter came in at $593.4 million versus the consensus estimate of $561.89 million.

Heidrick & Struggles (NASDAQ:HSII) 11% LOWER; reported Q3 EPS of $1.00, $0.14 better than the analyst estimate of $0.86. Revenue for the quarter came in at $255.2 million versus the consensus estimate of $267.29 million. Heidrick & Struggles sees Q4 2022 revenue of $215-235 million, versus the consensus of $263.5 million.

Qualtrics International Inc (NASDAQ:XM) 10% HIGHER; reported Q3 EPS of $0.04, $0.06 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $377.5 million versus the consensus estimate of $358.69 million. Qualtrics International sees Q4 2022 EPS of $0.02-$0.03, versus the consensus of ($0.01). Qualtrics International sees Q4 2022 revenue of $380-382 million, versus the consensus of $373.14 million. Qualtrics International sees FY2022 EPS of $0.04-$0.05, versus the consensus of ($0.07). Qualtrics International sees FY2022 revenue of $1.45-1.452 billion, versus the consensus of $1.42 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Calix, Inc. (NYSE:CALX) 5% HIGHER; reported Q3 EPS of $0.34, $0.11 better than the analyst estimate of $0.23. Revenue for the quarter came in at $236.3 million versus the consensus estimate of $215.23 million. Calix, Inc. sees Q4 2022 EPS of $0.22-$0.28, versus the consensus of $0.23. Calix, Inc. sees Q4 2022 revenue of $237-243 million, versus the consensus of $218 million.

Cadence Design Systems (NASDAQ:CDNS) 2% HIGHER; reported Q3 EPS of $1.06, $0.10 better than the analyst estimate of $0.96. Revenue for the quarter came in at $903 million versus the consensus estimate of $871.2 million. Cadence Design Systems sees Q4 2022 EPS of $0.89-$0.93, versus the consensus of $0.87. Cadence Design Systems sees Q4 2022 revenue of $870-890 million, versus the consensus of $866.61 million. Cadence Design Systems sees FY2022 EPS of $4.20-$4.24, versus the consensus of $4.12. Cadence Design Systems sees FY2022 revenue of $3.532-3.552 billion, versus the consensus of $3.5 billion.

Discover Financial Services (NYSE:DFS) 2% LOWER; reported Q3 EPS of $3.54, $0.19 worse than the analyst estimate of $3.73. Revenue net of interest expense was $3.48 billion vs consensus of $3.37 billion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.